Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Aaron S. Mansfield, Wendy K. Nevala, Elizabeth Ann T. Lieser, Alexey A. Leontovich & Svetomir N Markovic. (2013) The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma. OncoImmunology 2:5.
Read now
Read now
Alexander D Guminski & John F Thompson. (2009) Predicting response to IL-2 therapy for metastatic melanoma. Expert Review of Anticancer Therapy 9:11, pages 1571-1575.
Read now
Read now
Articles from other publishers (27)
Costanza Maria Cristiani, Mariaelena Capone, Cinzia Garofalo, Gabriele Madonna, Domenico Mallardo, Marilena Tuffanelli, Vito Vanella, Marta Greco, Daniela Patrizia Foti, Giuseppe Viglietto, Paolo Antonio Ascierto, Hergen Spits & Ennio Carbone. (2022) Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors. Frontiers in Immunology 13.
Crossref
Crossref
Silvia Selene Moreno-Guerrero, Arturo Ramírez-Pacheco, Luz María Rocha-Ramírez, Gabriela Hernández-Pliego, Pilar Eguía-Aguilar, María Argelia Escobar-Sánchez, Alfonso Reyes-López, Luis Enrique Juárez-Villegas & Juan José Luis Sienra-Monge. (2021) Association of Genetic Polymorphisms and Serum Levels of IL-6 and IL-8 with the Prognosis in Children with Neuroblastoma. Cancers 13:3, pages 529.
Crossref
Crossref
Ahmad A. Tarhini, Haris Zahoor, Yan Lin, Usha Malhotra, Cindy Sander, Lisa H. Butterfield & John M. Kirkwood. (2015) Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma. Journal for ImmunoTherapy of Cancer 3:1.
Crossref
Crossref
Ahmad A. Tarhini, Yan Lin, Haris Zahoor, Yongli Shuai, Lisa H. Butterfield, Steven Ringquist, Helen Gogas, Cindy Sander, Sandra Lee, Sanjiv S. Agarwala & John M. Kirwood. (2015) Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-? but Not Observation in Intermediate Risk Melanoma Patients. PLOS ONE 10:7, pages e0132745.
Crossref
Crossref
Xin Yao, Jiaqi Huang, Haihong Zhong, Nan Shen, Raffaella Faggioni, Michael Fung & Yihong Yao. (2014) Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics 141:2, pages 125-139.
Crossref
Crossref
Yi-Rang Na, Jin-Sub Lee, Seok-Jong Lee & Seung-Hyeok Seok. (2013) Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis. Melanoma Research 23:6, pages 434-443.
Crossref
Crossref
Aleksandra Niedzwiecki. (2012) Ascorbate supplementation inhibits growth and metastasis of B16FO melanoma and 4T1 breast cancer cells in vitamin C-deficient mice. International Journal of Oncology.
Crossref
Crossref
Lise Hoejberg, Lars Bastholt & Henrik Schmidt. (2012) Interleukin-6 and melanoma. Melanoma Research 22:5, pages 327-333.
Crossref
Crossref
Lise Hoejberg, Lars Bastholt, Julia S. Johansen, Ib Jarle Christensen, Julie Gehl & Henrik Schmidt. (2012) Serum interleukin-6 as a prognostic biomarker in patients with metastatic melanoma. Melanoma Research 22:4, pages 287-293.
Crossref
Crossref
Ahmad A. Tarhini & John M. Kirkwood. 2012. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
305
317
.
Sharon R. Pine, Leah E. Mechanic, Lindsey Enewold, Anil K. Chaturvedi, Hormuzd A. Katki, Yun-Ling Zheng, Elise D. Bowman, Eric A. Engels, Neil E. Caporaso & Curtis C. Harris. (2011) Increased Levels of Circulating Interleukin 6, Interleukin 8, C-Reactive Protein, and Risk of Lung Cancer. JNCI: Journal of the National Cancer Institute 103:14, pages 1112-1122.
Crossref
Crossref
A A Wani, S M Jafarnejad, J Zhou & G Li. (2011) Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway. Oncogene 30:24, pages 2778-2788.
Crossref
Crossref
Thao Pham, Pascal Claudepierre, Arnaud Constantin, Michel de Bandt, Bruno Fautrel, Laure Gossec, Jacques-Eric Gottenberg, Philippe Goupille, Séverine Guillaume, Eric Hachulla, Charles Masson, Jacques Morel, Xavier Puéchal, Alain Saraux, Thierry Schaeverbeke, Daniel Wendling, Eric Bruckert, Stanislas Pol, Xavier Mariette & Jean Sibilia. (2010) Tocilizumab: Therapy and safety management. Joint Bone Spine 77, pages S3-S100.
Crossref
Crossref
Roger Mouawad, Jean-Philippe Spano & David Khayat. (2010) Old and new serological biomarkers in melanoma: where we are in 2009. Melanoma Research 20:2, pages 67-76.
Crossref
Crossref
Joanne P. Lagmay, Wendy B. London, Thomas G. Gross, Amanda Termuhlen, Nicholas Sullivan, Amy Axel, Bethany Mundy, Mark Ranalli, Jason Canner, Patrick McGrady & Brett Hall. (2009)
Prognostic Significance of Interleukin-6 Single Nucleotide Polymorphism Genotypes in Neuroblastoma:
rs1800795
(Promoter) and
rs8192284
(Receptor)
. Clinical Cancer Research 15:16, pages 5234-5239.
Crossref
Crossref
Alison M. Karst, Kai Gao, Colleen C. Nelson & Gang Li. (2009) Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression. International Journal of Cancer 124:2, pages 494-501.
Crossref
Crossref
Rachel A. Egler, Susan M. Burlingame, Jed G. Nuchtern & Heidi V. Russell. (2008) Interleukin-6 and Soluble Interleukin-6 Receptor Levels as Markers of Disease Extent and Prognosis in Neuroblastoma. Clinical Cancer Research 14:21, pages 7028-7034.
Crossref
Crossref
Diana Santo Domingo & Elma D. Baron. 2008. Sunlight, Vitamin D and Skin Cancer. Sunlight, Vitamin D and Skin Cancer
187
202
.
David S. Hong, Laura S. Angelo & Razelle Kurzrock. (2007) Interleukin‐6 and its receptor in cancer. Cancer 110:9, pages 1911-1928.
Crossref
Crossref
R. E. Kast. (2007) Melanoma inhibition by cyclooxygenase inhibitors. Medical Oncology 24:1, pages 1-6.
Crossref
Crossref
O.M. Ahmed, R.G. Ahmed, M.M.S. Nada & M. Bahgat .. (2007) Does the Heat Stress Affect the Neurons Development in Some Central Nervous System Regions of Albino Rat Newborns?. Asian Journal of Animal and Veterinary Advances 2:3, pages 86-103.
Crossref
Crossref
Zoya R. Yurkovetsky, John M. Kirkwood, Howard D. Edington, Adele M. Marrangoni, Lyudmila Velikokhatnaya, Matthew T. Winans, Elieser Gorelik & Anna E. Lokshin. (2007) Multiplex Analysis of Serum Cytokines in Melanoma Patients Treated with Interferon-α2b. Clinical Cancer Research 13:8, pages 2422-2428.
Crossref
Crossref
Balázs Ádám, László Tóth, Gabriella Pásti, Margit Balázs & Róza Ádány. (2006) Contact stimulation of fibroblasts for tenascin production by melanoma cells. Melanoma Research 16:5, pages 385-391.
Crossref
Crossref
P. Metharom, F.W. Velten & S. Goerdt. (2006) Highly phagocytic, CD4hi, CD14hi and CD16hi antigen-presenting cells modulated by tumour-conditioned media retain the capacity to mature and induce TH1 T-cell proliferation. Molecular Immunology 43:13, pages 2070-2082.
Crossref
Crossref
Dan Leibovici, H. Barton Grossman, Colin P. Dinney, Randal E. Millikan, Seth Lerner, Yunfei Wang, Jian Gu, Qiong Dong & Xifeng Wu. (2005) Polymorphisms in Inflammation Genes and Bladder Cancer: From Initiation to Recurrence, Progression, and Survival. Journal of Clinical Oncology 23:24, pages 5746-5756.
Crossref
Crossref
Martin McCarter, Jason Clarke, Donald Richter & Cara Wilson. (2005) Melanoma skews dendritic cells to facilitate a T helper 2 profile. Surgery 138:2, pages 321-328.
Crossref
Crossref
Jonathan Cools-Lartigue, Jean Claude Marshall, Amanda L. Caissie, Vinicius S. Saraiva & Miguel N. BurnierJr.Jr.. (2004) Secretion of interleukin-6 and prostaglandin E2 during uveal melanoma-monocyte in vitro interactions. Experimental Eye Research 79:4, pages 451-454.
Crossref
Crossref